Targeted Lymph Node Immunization with Serotype-Specific Dengue VLP Vaccines Enhances Antibody Avidity and Specificity

Area of Science:

• Immunology
• Vaccinology
• Virology

Background:

• Dengue virus (DENV) poses a global health challenge due to its four serotypes, complicating vaccine development.
• Cross-reactive antibodies can lead to antibody-dependent enhancement (ADE), increasing disease severity.

Purpose of the Study:

• To develop a vaccine strategy that induces strictly serotype-specific immune responses.
• To explore targeting individual lymph nodes (LNs) for simultaneous, independent immune responses, reducing cross-reactivity and improving vaccine specificity.

Main Methods:

• Individual LNs were targeted to induce specific germinal centers (GCs) for different antigens.
• Virus-like particle (VLP)-based vaccines for DENV1 and DENV4 were administered into separate LNs.
• Immune response specificity was compared to subcutaneous administration of a mixed vaccine.

Main Results:

• Targeting distinct LNs elicited antibodies with significantly higher avidity.
• This segregation approach led to a more refined selection of high-affinity B cells.
• Separate LN targeting induced a more potent and serotype-specific neutralizing response compared to a vaccine mixture.

Conclusions:

• Targeting individual LNs enhances immune response specificity and potency, particularly for flaviviruses.
• Administering vaccines into distinct watersheds offers a potential human application for this approach.